MedTrace Logo

Home Based Monitoring of Kidney Transplants Utilizing Capillary Microsamples

NCT04369612 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2024-04-04

No results posted yet for this study

Summary

Renal transplant recipients are followed as out patients at the transplant center for about 8 weeks after surgery. Between 1-2 weeks after surgery, 50 standard immunological patients will be randomized (1:1) to either follow standard of care (SOC) or having every second poli clinical visit without entering the hospital HBM; Home Based Monitoring). They are to take a capillary finger-prick blood sample themselves, send it to the laboratory for analysis and then they will get a telecom follow-up that day from their transplant physician. Outcome is no difference with regards to being able to follow the randomized follow-up procedure.

Conditions

  • Kidney Transplant Failure and Rejection

Interventions

PROCEDURE

Standard follow-up

Standard post-transplant follow-up

PROCEDURE

Home-based monitoring

Patients take capillary blood sample by finger-prick and send to lab for analyses. Telecom follow-up that day by treating physician

Sponsors & Collaborators

  • Oslo University Hospital

    lead OTHER

Principal Investigators

  • Karsten Midtvedt, MD, PhD · Oslo University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-28
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Norway

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04369612 on ClinicalTrials.gov